GW Pharmaceuticals plc

Offer details

Expected size of offer (M):	-
Expected first date of trading:	28/06/2001
Market:	AIM
Location of address at which admission document will be available:	Collins Stewart Limited 9th Floor 88 Wood Street London EC2V 7QR
Date at which admission document will be available:	-

Advisors

Sponsor:	-
Nominated Advisor (AIM Companies):	Collins Stewart Limited
Nominated Broker (AIM Companies):	Collins Stewart Limited
Financial PR Advisors:	-

Company details

Name	Role
Dr Geoffrey William Guy	Executive Chairman
Justin David Gover	Managing Director
Dr Brian Anthony Whittle	Scientific Director
Jonathan Michael Eastfield Laughton	Finance Director
Peter Mountford	Non-executive Director

Facts and Figures

Fiscal year end:	- -
Incorporated in:	England & Wales
Website URL:	http://

Description of business:
GW Pharmaceuticals is a pharmaceutical group developing a portfolio of prescription medecines derived from cannabis to meet patient needs in a wide range of therapeutic conditions.

Person(s) interested:
Dr Geoffrey William Guy - 31.5% Justin David Gover - 5.1% Dr Brian Anthony Whittle - 13.9% Preston L Parish - 9.9%